Haemonetics Corporation (HAE) - Financial and Strategic SWOT Analysis Review

Date: July 12, 2016
Pages: 66
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: HF2FD737A14EN
Leaflet:

Download PDF Leaflet

Haemonetics Corporation (HAE) - Financial and Strategic SWOT Analysis Review
Haemonetics Corporation (HAE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Haemonetics Corporation (Haemonetics) is a healthcare company, which offers blood management technology and software solutions. The company’s portfolio consists of integrated devices, information management software, and consulting services for improving clinical outcomes. It also offers a comprehensive suite of solutions to the blood supply chain, which ranges from plasma and blood collectors to hospitals. Haemonetics markets its products to blood collection groups and independent blood centers, national health organizations, hospital service providers, hospitals, group purchasing organizations, and bio-pharmaceutical companies through a direct sales force and independent distributors. It has subsidiaries in the Americas, Asia and Europe. Haemonetics is headquartered in Braintree, Massachusetts, the US.

Haemonetics Corporation Key Recent Developments

May 09, 2016: Haemonetics Provides Fiscal 2017 Guidance
May 09, 2016: Haemonetics Announces Christopher Simon as President and Chief Executive Officer
May 02, 2016: Haemonetics Reports 4th Quarter Fiscal 2016 Revenue of $243 Million, Constant Currency Revenue Growth of 10% and 7% As Reported
Apr 14, 2016: Haemonetics Announces CFO's Retirement
Feb 01, 2016: Haemonetics Reports 3rd Quarter Fiscal 2016 Revenue of $233 Million, Constant Currency Revenue Growth of 4% and 1% As Reported

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
SECTION 1 - ABOUT THE COMPANY

Haemonetics Corporation - Key Facts
Haemonetics Corporation - Key Employees
Haemonetics Corporation - Key Employee Biographies
Haemonetics Corporation - Major Products and Services
Haemonetics Corporation - Medical Equipment Pipeline Products Data
Haemonetics Corporation Pipeline Products by Equipment Type
Haemonetics Corporation Pipeline Products by Development Stage
Haemonetics Corporation - History
Haemonetics Corporation - Company Statement
Haemonetics Corporation - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Haemonetics Corporation - Business Description
Business Description - Blood Center Products
Blood Center Products - Overview
Blood Center Products - Financials
Business Description - Hospital Products
Hospital Products - Overview
Hospital Products - Financials
Business Description - Plasma Products
Plasma Products - Overview
Plasma Products - Financials
Business Description - Software Solutions
Software Solutions - Overview
Software Solutions - Financials
Haemonetics Corporation - Corporate Strategy
Haemonetics Corporation - SWOT Analysis
SWOT Analysis - Overview
Haemonetics Corporation - Strengths
Strength - Plasma Disposables
Strength - Research and Development Capabilities
Strength - Operations in the US and Asia
Haemonetics Corporation - Weaknesses
Weakness - Product Safety
Weakness - Cost Control
Haemonetics Corporation - Opportunities
Opportunity - Strategic Initiatives
Opportunity - Outlook for Blood Transfusion: the US
Opportunity - Plasma Derived Proteins Market: the US
Opportunity - Outlook for Medical Device Industry: the US
Haemonetics Corporation - Threats
Threat - Transfusion Transmitted Infections
Threat - Dependence on Third Party Suppliers
Threat - Competition
Threat - Stringent Regulations
Haemonetics Corporation - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Haemonetics Corporation, Medical Equipment, Deals By Year, 2010 to YTD 2016
Haemonetics Corporation, Medical Equipment, Deals By Type, 2010 to YTD 2016
Haemonetics Corporation, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

May 09, 2016: Haemonetics Provides Fiscal 2017 Guidance
May 09, 2016: Haemonetics Announces Christopher Simon as President and Chief Executive Officer
May 02, 2016: Haemonetics Reports 4th Quarter Fiscal 2016 Revenue of $243 Million, Constant Currency Revenue Growth of 10% and 7% As Reported
Apr 14, 2016: Haemonetics Announces CFO's Retirement
Feb 01, 2016: Haemonetics Reports 3rd Quarter Fiscal 2016 Revenue of $233 Million, Constant Currency Revenue Growth of 4% and 1% As Reported
Nov 04, 2015: Haemonetics Reports 2nd Quarter Fiscal 2016 Revenue of $220 Million and Adjusted EPS of $0.44, Affirms Recent Full Fiscal Year Guidance
Oct 22, 2015: Haemonetics to Display a Powerful Line-up of New Products and Solutions at This Year's AABB Annual Meeting
Sep 29, 2015: Haemonetics Corporation Appoints Ron Gelbman as Interim CEO; CEO Brian Concannon Resigns
Jul 27, 2015: Haemonetics Reports 1St Quarter Fiscal 2016 Revenue Of $213 Million and Adjusted Eps Of $0.35, Reaffirms Full Fiscal Year Guidance
Jul 14, 2015: Malaysia, The Hub Of Medical Device Manufacturing In Asean

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Haemonetics Corporation, Key Facts
Haemonetics Corporation, Key Employees
Haemonetics Corporation, Key Employee Biographies
Haemonetics Corporation, Major Products and Services
Haemonetics Corporation Pipeline Products by Equipment Type
Haemonetics Corporation Number of Pipeline Products by Development Stage
Haemonetics Corporation Pipeline Products Summary by Development Stage
Haemonetics Corporation, History
Haemonetics Corporation, Other Locations
Haemonetics Corporation, Subsidiaries
Haemonetics Corporation, Key Competitors
Haemonetics Corporation, Ratios based on current share price
Haemonetics Corporation, Annual Ratios
Haemonetics Corporation, Interim Ratios
Haemonetics Corporation, Medical Equipment, Deals By Year, 2010 to YTD 2016
Haemonetics Corporation, Medical Equipment, Deals By Type, 2010 to YTD 2016
Haemonetics Corporation, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

Haemonetics Corporation Pipeline Products by Equipment Type
Haemonetics Corporation Pipeline Products by Development Stage
Haemonetics Corporation, Performance Chart (2012 - 2016)
Haemonetics Corporation, Ratio Charts
Haemonetics Corporation, Medical Equipment, Deals By Year, 2010 to YTD 2016
Haemonetics Corporation, Medical Equipment, Deals by Type, 2010 to YTD 2016
Skip to top


Ask Your Question

Haemonetics Corporation (HAE) - Financial and Strategic SWOT Analysis Review
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: